Free Trial

The Pennant Group (NASDAQ:PNTG) Earns Overweight Rating from Stephens

The Pennant Group logo with Medical background

Stephens reaffirmed their overweight rating on shares of The Pennant Group (NASDAQ:PNTG - Free Report) in a research report report published on Thursday, Benzinga reports. They currently have a $25.00 price target on the stock.

Several other equities research analysts have also commented on PNTG. Royal Bank of Canada increased their price objective on shares of The Pennant Group from $21.00 to $26.00 and gave the company an outperform rating in a research note on Thursday, May 9th. Oppenheimer upped their price objective on The Pennant Group from $18.00 to $22.00 and gave the company an outperform rating in a research note on Friday, March 1st. Finally, Truist Financial raised their price objective on shares of The Pennant Group from $22.00 to $25.00 and gave the stock a hold rating in a report on Wednesday, May 15th.

Read Our Latest Research Report on PNTG

The Pennant Group Stock Down 2.7 %

PNTG stock traded down $0.61 during mid-day trading on Thursday, reaching $22.04. 89,380 shares of the company traded hands, compared to its average volume of 153,033. The stock has a market cap of $662.30 million, a price-to-earnings ratio of 40.81, a P/E/G ratio of 2.40 and a beta of 2.02. The Pennant Group has a fifty-two week low of $10.31 and a fifty-two week high of $24.09. The firm's 50 day moving average price is $22.15 and its 200 day moving average price is $18.47. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.51.


The Pennant Group (NASDAQ:PNTG - Get Free Report) last announced its quarterly earnings results on Monday, May 6th. The company reported $0.15 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.15. The business had revenue of $156.92 million during the quarter, compared to the consensus estimate of $146.01 million. The Pennant Group had a return on equity of 13.42% and a net margin of 2.86%. As a group, equities research analysts predict that The Pennant Group will post 0.73 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in PNTG. 8 Knots Management LLC bought a new position in The Pennant Group in the 4th quarter worth about $25,578,000. Boone Capital Management LLC bought a new position in The Pennant Group in the fourth quarter valued at $4,589,000. Peregrine Capital Management LLC purchased a new stake in The Pennant Group during the first quarter valued at about $6,403,000. Allianz Asset Management GmbH purchased a new position in shares of The Pennant Group in the 4th quarter worth about $2,351,000. Finally, Kent Lake Capital LLC lifted its position in The Pennant Group by 34.6% in the 3rd quarter. Kent Lake Capital LLC now owns 583,631 shares of the company's stock worth $6,496,000 after buying an additional 150,187 shares during the last quarter. Institutional investors own 85.88% of the company's stock.

About The Pennant Group

(Get Free Report)

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.

Further Reading

→ Collapse of the Petrodollar (From Colonial Metals) (Ad)

Should you invest $1,000 in The Pennant Group right now?

Before you consider The Pennant Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Pennant Group wasn't on the list.

While The Pennant Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

NVIDIA Tops Microsoft and Apple for Most Valuable Company

NVIDIA Tops Microsoft and Apple for Most Valuable Company

Join us as we dive deep into NVIDIA's meteoric rise and what it signifies for current and future investors.

Related Videos

3 Strong Buy Stocks for a Summer Surge
Roblox Reality Check: Why the Metaverse Isn’t Saving the Stock!
Amazon Stands Tall: New Highs Are in Sight

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines